Differential diagnoses: How to determine cause of visual field loss

Article

Management decisions for a patient who presents with a visual field defect should never be made before considering a host of other etiologies that can masquerade as glaucoma by the type of visual field loss.

New York-Management decisions for a patient who presents with a visual field defect (VFD) should never be made before considering a host of other etiologies that can masquerade as glaucoma by the type of visual field loss (VFL), said Sherry J. Bass, OD, FAAO, at International Vision Expo East.

Consider big picture

VFL associated with glaucoma presents initially as paracentral defects with progression to nasal step defects, arcuate and Bjerrum defects, altitudinal defects, and ultimately, if the disease is not controlled, peripheral field constriction. For each of these types of defects, there are different etiologies to consider as an alternative diagnosis.

Non-glaucomatous etiologies of paracentral field loss include hereditary macular disease, such as Stargardt macular degeneration and cone dystrophy, and optic pits. Superior paracentral VFLs can be found in patients with a hereditary macular disease as a result of their typical use of superior eccentric fixation to achieve better vision.

In patients with an optic pit, usually located at the inferior temporal border of the optic nerve head, paracentral field loss is secondary to loss of the retinal nerve fiber layer between the macula and optic nerve that can exist in this condition, Dr. Bass explained.

Nasal field defects are also a sign of early glaucoma but can alternatively be caused by optic disc drusen. Diagnosis of optic disc drusen may be challenged by the fact that the lesions may be buried in younger patients.

"The finding of an optic nerve head with blurry disc borders and no cupping in a patient with a nasal field defect should suggest the diagnosis of optic nerve drusen," Dr. Bass said.

"Further evaluation should include B-scan ultrasonography," she continued. "However, this imaging is only effective for identifying drusen that are calcified, which includes about 50% of disc drusen."

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.